STAVUDINE
Substance profile for UNII BO9LE4QFZF, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 18283Substance Identity#
- UNII
- BO9LE4QFZF
- Preferred term
- STAVUDINE
- Registry number
- 3056-17-5
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C10H12N2O4
Structure render from PubChem CID 18283Chemical And Database Identifiers#
- InChIKey
- XNKLLVCARDGLGL-JGVFFNPUSA-N
- SMILES
- CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O
- RxCUI
- 59763
- PubChem
- 18283
- NCIt
- C1428
- INN ID
- 6775
DailyMed Socrata Ingredients#
Type, DailyMed label, SPL version table| Type | DailyMed label | SPL version |
|---|
| ACTIVE MOIETY | These highlights do not include all the information needed to use stavudine safely and effectively. See full prescribing information for stavudine capsules. Stavudine Capsules, USP Initial U.S. Approval: 1994 | 1 |
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use stavudine safely and effectively. See full prescribing information for stavudine capsules. Stavudine Capsules, USP Initial U.S. Approval: 1994 | 1 |
| ACTIVE INGREDIENT | ZERIT ® (stavudine) Capsules ZERIT ® (stavudine) for Oral Solution | 3 |
| ACTIVE MOIETY | ZERIT ® (stavudine) Capsules ZERIT ® (stavudine) for Oral Solution | 3 |
| ACTIVE INGREDIENT | 081991e0-eee4-4fa3-ac3d-0c32cb03e7f3 | 1 |
| ACTIVE MOIETY | 081991e0-eee4-4fa3-ac3d-0c32cb03e7f3 | 1 |
| ACTIVE MOIETY | 752d2c13-5ca5-40b3-b066-55a9b6b1287a | 1 |
| ACTIVE INGREDIENT | 752d2c13-5ca5-40b3-b066-55a9b6b1287a | 1 |
| ACTIVE INGREDIENT | 12cbb604-d5f8-49ee-962c-bb12f4105bb3 | 2 |
| ACTIVE MOIETY | 12cbb604-d5f8-49ee-962c-bb12f4105bb3 | 2 |
| ACTIVE MOIETY | STAVUDINE (STAVUDINE) CAPSULE [REMEDYREPACK INC. ] | 80 |
| ACTIVE INGREDIENT | STAVUDINE (STAVUDINE) CAPSULE [REMEDYREPACK INC. ] | 80 |
| ACTIVE INGREDIENT | ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.] | 23 |
| ACTIVE MOIETY | ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) CAPSULE, GELATIN COATED ZERIT (STAVUDINE) POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.] | 23 |
| ACTIVE INGREDIENT | STAVUDINE POWDER, FOR SOLUTION [AUROBINDO PHARMA LIMITED] | 9 |
| ACTIVE MOIETY | STAVUDINE POWDER, FOR SOLUTION [AUROBINDO PHARMA LIMITED] | 9 |
| ACTIVE MOIETY | STAVUDINE CAPSULE [AUROBINDO PHARMA LIMITED] | 8 |
| ACTIVE INGREDIENT | STAVUDINE CAPSULE [AUROBINDO PHARMA LIMITED] | 8 |
| ACTIVE MOIETY | STAVUDINE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 7 |
| ACTIVE INGREDIENT | STAVUDINE CAPSULE [MYLAN PHARMACEUTICALS INC.] | 7 |
| ACTIVE INGREDIENT | STAVUDINE FOR SOLUTION [CIPLA LIMITED] | 4 |
| ACTIVE MOIETY | STAVUDINE FOR SOLUTION [CIPLA LIMITED] | 4 |
| ACTIVE INGREDIENT | STAVUDINE SOLUTION [BOCA PHARMACAL, LLC] | 2 |
| ACTIVE MOIETY | STAVUDINE SOLUTION [BOCA PHARMACAL, LLC] | 2 |
| ACTIVE MOIETY | STAVUDINE CAPSULE [KAISER FOUNDATION HOSPITALS] | 1 |
| ACTIVE INGREDIENT | STAVUDINE CAPSULE [KAISER FOUNDATION HOSPITALS] | 1 |
| ACTIVE INGREDIENT | STAVUDINE POWDER, FOR SOLUTION [EDENBRIDGE PHARMACEUTICALS, LLC] | 1 |
| ACTIVE MOIETY | STAVUDINE POWDER, FOR SOLUTION [EDENBRIDGE PHARMACEUTICALS, LLC] | 1 |